TFStoop Profile Banner
Thomas Stoop Profile
Thomas Stoop

@TFStoop

Followers
455
Following
1K
Statuses
249

MD, PhD candidate HPB Surgery Amsterdam UMC 🇳🇱| Former Research Fellow Karolinska University Hospital 🇸🇪 & University of Colorado 🇺🇸

Amsterdam, Nederland
Joined June 2022
Don't wanna be here? Send us removal request.
@TFStoop
Thomas Stoop
1 year
Today in @NatRevGastroHep, review BRPC-LAPC #PancreaticCancer 📌 Preoperative chemotherapy & radiation 📌 A-B-C (re)staging & surgical decision-making 📌Clinical research agenda Great team effort 🇩🇪🇺🇸🇳🇱
4
38
101
@TFStoop
Thomas Stoop
9 hours
RT @MarcBesselink: How do costs of robot 🤖 vs open pancreatoduodenectomy compare? Will costs become similar over time? 588 pts A’dam 🇳🇱 (2…
0
17
0
@TFStoop
Thomas Stoop
5 days
RT @CUDeptSurg: A new study shows that giving chemotherapy before surgery to patients leads to better outcomes compared to immediate surger…
0
1
0
@TFStoop
Thomas Stoop
9 days
RT @julia_menso: Looking back at an incredible @alpshpb meeting and delighted to have been awarded the Best Mini-Oral Presentation for our…
0
2
0
@TFStoop
Thomas Stoop
11 days
RT @alpshpb: @chiaro_del from @CUCancerCenter @CUDeptSurg starts the afternoon educational session with a fantastic overview of treating mo…
0
8
0
@TFStoop
Thomas Stoop
18 days
RT @ArndtVogel: Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX @JAMAOnc ht…
0
5
0
@TFStoop
Thomas Stoop
19 days
RT @JAMAOnc: Adjuvant (m)FOLFIRINOX and other multiagent chemotherapy regimens following resection of localized pancreatic adenocarcinoma a…
0
9
0
@TFStoop
Thomas Stoop
19 days
👉🏼 Full text here:
0
0
0
@TFStoop
Thomas Stoop
19 days
👉🏼 full text:
0
1
2
@TFStoop
Thomas Stoop
24 days
RT @Gio_Marchegiani: Neoadjuvant chemotherapy for left 👈 sided resectable PDAC 🪡 72% of US received adjuvant 💉 NAT had better OS (53 🆚 37…
0
19
0
@TFStoop
Thomas Stoop
25 days
RT @ArndtVogel: The impact of neoadjuvant therapy in patients with left-sided resectable #PDAC @Annals_Oncology 🔎international multicenter…
0
18
0
@TFStoop
Thomas Stoop
26 days
@EmmanuelMelloul @Annals_Oncology @e_rangelova @TessvRamshorst @MarcBesselink @chiaro_del @e_mips @CUpancreas @CancerCenterAms @EmmanuelMelloul The effect of NAT was increased in patients with a larger tumor on imaging at diagnosis and in patients with higher serum CA19.9 at diagnosis. Nevertheless, RCT is needed since these findings are based on a surgical cohort.
0
0
2
@TFStoop
Thomas Stoop
26 days
RT @Annals_Oncology: 🆕article in press: The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an inte…
0
17
0
@TFStoop
Thomas Stoop
29 days
Full text available here:
0
2
7
@TFStoop
Thomas Stoop
1 month
RT @CUDeptSurg: It was a packed room at today's Research Seminar Series featuring @drfrancosv, MD, of @CUSurgOnc and @yujess2000, MD, of th…
0
3
0
@TFStoop
Thomas Stoop
2 months
RT @chiaro_del: Current and past research fellows. Because once you join @CUpancreas you always remain part of the family! @ObaAtsushi @Hi
0
4
0
@TFStoop
Thomas Stoop
4 months
RT @YouppiePancreas: 📊Survey on pancreatic enzyme replacement therapy availability in Europe 🌍 What is happening in your area? 🕵🏼 Spread th…
0
7
0